Research shows citrus and grape compounds may protect against type 2 diabetes
Nov 2 2025 A new Italian study reveals that a daily blend of citrus and grape extracts with…
Stem cells show promise in preventing post-heart attack heart failure
Patients with weak heart function who receive stem cell therapy shortly after a heart attack are at lower…
New European trial tests subcutaneous EEG technology for people with epilepsy
A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is…
Digital tools and chatbots can expand genetic counseling for young cancer survivors
A groundbreaking new study from the Alliance for Clinical Trials in Oncology aims to test whether digital tools…
Early trial finds promise for avelumab and radiation in treating leptomeningeal disease
Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
Tai chi improves memory and sleep in older adults with type 2 diabetes
A clinical trial shows that practicing Tai Chi online can sharpen thinking skills and improve sleep in older…
Trauma-focused CBT could offer hope for young PTSD sufferers
A specialist form of therapy could offer hope for some of the most vulnerable young PTSD sufferers –…
Gene-Edited Pig Kidney Xenotransplants Get IND Clearance for Clinical Trials
Credit: Marcela Ruth Romero / iStock / Getty Images Plus In January 2025, Tim Andrews was non-ambulatory, in…
Constipation drug found to slow renal function decline in CKD patients
Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to…
Griffith University launches groundbreaking treatment trial for spinal cord injury
A Phase 1 human clinical trial to treat chronic spinal cord injury, the first of its kind in…
New drug-releasing system eliminates tumors in 82% of high-risk bladder cancer patients
A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for…